AYTU BIOPHARMA, INC Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-10-24: Form ARS; Period of report 2025-06-30; Description ARS; Document aytuars.pdf.
- 2025-03-28: Form ARS; Period of report 2024-06-30; Description ARS; Document aytuars.pdf.
- 2024-05-10: Form ARS; Period of report 2023-06-30; Description Annual report to security holders; Document aytu_ars.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-10-24 | ARS | 2025-06-30 | ARS | aytuars.pdf |
| 2025-03-28 | ARS | 2024-06-30 | ARS | aytuars.pdf |
| 2024-05-10 | ARS | 2023-06-30 | Annual report to security holders | aytu_ars.pdf |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |